Why Long-Term TD Management Still Falls Through the Cracks

By Gina ShawThe growing recognition of tardive dyskinesia (TD) as a treatable condition has shifted attention away from whether therapy exists to a more complicated question: Once TD has been identified, who is responsible for managing it over time?“Tardive dyskinesia has historically been thought of as a medication-induced adverse event, but it’s a diagnosable condition,” said Stephen Saklad, PharmD, BCCP, a clinical professor emeritus at The University of Texas at Austin Coll